[New strategy in type 2 diabetes tested in clinical trials. Glucagon-like peptide 1 (GLP-1) affects basic caused of the disease].
Year: 2005
Type: article
Source: PubMed
Author: Bo Ahrén
Institution: Lund University
Language: Swedish
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1846619494
